86 related articles for article (PubMed ID: 18656257)
1. Apoptotic effects on B-cell chronic lymphocytic leukemia (B-CLL) cells of heterocyclic compounds isolated from Guttiferaes.
Menasria F; Azebaze AG; Billard C; Faussat AM; Nkengfack AE; Meyer M; Kolb JP
Leuk Res; 2008 Dec; 32(12):1914-26. PubMed ID: 18656257
[TBL] [Abstract][Full Text] [Related]
2. Xanthones from the seeds of Allanblackia monticola and their apoptotic and antiproliferative activities.
Azebaze AG; Menasria F; Noumi LG; Nguemfo EL; Tchamfo MF; Nkengfack AE; Kolb JP; Meyer M
Planta Med; 2009 Feb; 75(3):243-8. PubMed ID: 19053018
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress accelerates spontaneous apoptosis of B-chronic lymphocytic leukemia lymphocytes.
Djurdjevic P; Zelen I; Ristic P; Jovanovic I; Jakovljevic V; Baskic D; Popovic S; Arsenijevic N
J BUON; 2009; 14(2):281-7. PubMed ID: 19650179
[TBL] [Abstract][Full Text] [Related]
4. Pro-apoptotic properties of hyperforin in leukemic cells from patients with B-cell chronic lymphocytic leukemia.
Quiney C; Billard C; Faussat AM; Salanoubat C; Ensaf A; Naït-Si Y; Fourneron JD; Kolb JP
Leukemia; 2006 Mar; 20(3):491-7. PubMed ID: 16424868
[TBL] [Abstract][Full Text] [Related]
5. Bendamustine is effective in p53-deficient B-cell neoplasms and requires oxidative stress and caspase-independent signaling.
Roué G; López-Guerra M; Milpied P; Pérez-Galán P; Villamor N; Montserrat E; Campo E; Colomer D
Clin Cancer Res; 2008 Nov; 14(21):6907-15. PubMed ID: 18980985
[TBL] [Abstract][Full Text] [Related]
6. Predominantly post-transcriptional regulation of activation molecules in chronic lymphocytic leukemia: the case of transferrin receptors.
Chiotoglou I; Smilevska T; Samara M; Likousi S; Belessi C; Athanasiadou I; Stavroyianni N; Samara S; Laoutaris N; Vamvakopoulos N; Anagnostopoulos A; Fassas A; Stamatopoulos K; Kollia P
Blood Cells Mol Dis; 2008; 41(2):203-9. PubMed ID: 18621559
[TBL] [Abstract][Full Text] [Related]
7. The novel tubulin-targeting agent pyrrolo-1,5-benzoxazepine-15 induces apoptosis in poor prognostic subgroups of chronic lymphocytic leukemia.
McElligott AM; Maginn EN; Greene LM; McGuckin S; Hayat A; Browne PV; Butini S; Campiani G; Catherwood MA; Vandenberghe E; Williams DC; Zisterer DM; Lawler M
Cancer Res; 2009 Nov; 69(21):8366-75. PubMed ID: 19826055
[TBL] [Abstract][Full Text] [Related]
8. High intracellular content of cyclin-dependent kinase inhibitor p27(Kip1) in early- and intermediate stage B-cell chronic lymphocytic leukemia lymphocytes predicts rapid progression of the disease.
Wolowiec D; Wojtowicz M; Ciszak L; Kosmaczewska A; Frydecka I; Potoczek S; Urbaniak-Kujda D; Kapelko-Slowik K; Kuliczkowski K
Eur J Haematol; 2009 Apr; 82(4):260-6. PubMed ID: 19187271
[TBL] [Abstract][Full Text] [Related]
9. Role of decreased production of interleukin-10 and interferon-gamma in spontaneous apoptosis of B-chronic lymphocytic leukemia lymphocytes in vitro.
Djurdjevic P; Zelen I; Ristic P; Baskic D; Popovic S; Arsenijevic N
Arch Med Res; 2009 Jul; 40(5):357-63. PubMed ID: 19766898
[TBL] [Abstract][Full Text] [Related]
10. Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo.
Di Ianni M; Moretti L; Terenzi A; Bazzucchi F; Del Papa B; Bazzucchi M; Ciurnelli R; Lucchesi A; Sportoletti P; Rosati E; Marconi PF; Falzetti F; Tabilio A
Cytotherapy; 2009; 11(1):86-96. PubMed ID: 19153855
[TBL] [Abstract][Full Text] [Related]
11. A novel paradigm to trigger apoptosis in chronic lymphocytic leukemia.
Loeder S; Zenz T; Schnaiter A; Mertens D; Winkler D; Döhner H; Debatin KM; Stilgenbauer S; Fulda S
Cancer Res; 2009 Dec; 69(23):8977-86. PubMed ID: 19920200
[TBL] [Abstract][Full Text] [Related]
12. In vitro response of stimulated B-CLL lymphocytes of patients treated with Viscum album L. extracts.
Büssing A; Kochskämper H; Rieger S; Schierholz JM; Schlodder D; Schietzel M
Anticancer Res; 2007; 27(6B):4195-200. PubMed ID: 18225591
[TBL] [Abstract][Full Text] [Related]
13. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
14. Expression and function of toll like receptors in chronic lymphocytic leukaemia cells.
Muzio M; Scielzo C; Bertilaccio MT; Frenquelli M; Ghia P; Caligaris-Cappio F
Br J Haematol; 2009 Feb; 144(4):507-16. PubMed ID: 19036098
[TBL] [Abstract][Full Text] [Related]
15. Leukemia cutis (involving chronic lymphocytic leukemia) within excisional specimens: a series of 6 cases.
Walther BS; Gibbons G; Chan EF; Ziselman E; Rothfleisch JE; Willard RJ; Baldassano MF
Am J Dermatopathol; 2009 Apr; 31(2):162-5. PubMed ID: 19318802
[TBL] [Abstract][Full Text] [Related]
16. Glutamate dehydrogenase activity in lymphocytes of B-cell chronic lymphocytic leukaemia patients.
Pajic T; Cernelc P; Sesek Briski A; Lejko-Zupanc T; Malesic I
Clin Biochem; 2009 Nov; 42(16-17):1677-84. PubMed ID: 19683518
[TBL] [Abstract][Full Text] [Related]
17. Flavopiridol-induced iNOS downregulation during apoptosis of chronic lymphocytic leukemia cells is caspase-dependent.
Billard C; Menasria F; Quiney C; Faussat AM; Kolb JP
Leuk Res; 2008 May; 32(5):755-60. PubMed ID: 17981326
[TBL] [Abstract][Full Text] [Related]
18. Cell proliferation and death: forgotten features of chronic lymphocytic leukemia B cells.
Chiorazzi N
Best Pract Res Clin Haematol; 2007 Sep; 20(3):399-413. PubMed ID: 17707829
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis in B-CLL: the relationship between higher ex vivo spontaneous apoptosis before treatment in III-IV Rai stage patients and poor outcome.
Sieklucka M; Pozarowski P; Bojarska-Junak A; Hus I; Dmoszynska A; Rolinski J
Oncol Rep; 2008 Jun; 19(6):1611-20. PubMed ID: 18497973
[TBL] [Abstract][Full Text] [Related]
20. Glucosylceramide synthase inhibitors sensitise CLL cells to cytotoxic agents without reversing P-gp functional activity.
Gerrard G; Butters TD; Ganeshaguru K; Mehta AB
Eur J Pharmacol; 2009 May; 609(1-3):34-9. PubMed ID: 19285492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
